FHND1002 for ALS Treatment: Phase 2

NCT07138014 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

180

Enrollment

INDUSTRY

Sponsor class

Conditions

Amyotrophic Lateral Sclerosis (ALS)

Interventions

DRUG: FHND1002 100mg
DRUG: FHND1002 200mg
DRUG: Placebo

Sponsor

Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.